Back to search

Article

Hydroxychloroquine Immediate Release Tablets: Formulation and Evaluation of a Solid Dosage Form

2021-03-10

Abstract excerpt

Hydroxychloroquine (HCQ) is a quinoline derivate used for the treatment of malaria and rheumatoid disorders. During early phases of the SARS-CoV2 (COVID-19) pandemic, preliminary and later not substantiated reports suggested that HCQ might benefit COVID-19 patients. This had sparked a worldwide and rapidly rising demand for HCQ drug products. Consequently, patients with pre-existing rheumatic diseases in Switzerla...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fa236363-bdef-56fc-8134-4cca1eb113b2
DOI
10.26434/chemrxiv.14170508.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Hydroxychloroquine Immediate Release Tablets: Formulation and Evaluation of a Solid Dosage FormDOI 10.26434/chemrxiv.14170508.v1
Select a neighboring publication to make it the new centre.